{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T18:55:21Z","timestamp":1773860121838,"version":"3.50.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"48","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Heart J"],"published-print":{"date-parts":[[2016,12,21]]},"DOI":"10.1093\/eurheartj\/ehw662","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T08:25:23Z","timestamp":1484295923000},"page":"3545-3548","source":"Crossref","is-referenced-by-count":2,"title":["Updates on prevention: obesity, ezetimibe, PCSK9, and HIV infection"],"prefix":"10.1093","volume":"37","author":[{"given":"Thomas F.","family":"L\u00fcscher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,1,13]]},"reference":[{"key":"2017011300250937000_37.48.3545.1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv089"},{"key":"2017011300250937000_37.48.3545.2","doi-asserted-by":"crossref","unstructured":"Rosengren A Aberg M Robertson J Waern M Schaufelberger M Kuhn G \u00c5berg D Schi\u00f6ler L Tor\u00e9n K. Body weight in adolescence and long-term risk of early heart failure in adulthood among men in Sweden. Eur Heart J 2016; doi:10.1093\/eurheartj\/ehw221.","DOI":"10.1093\/eurheartj\/ehw221"},{"key":"2017011300250937000_37.48.3545.3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu123"},{"key":"2017011300250937000_37.48.3545.4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw124"},{"key":"2017011300250937000_37.48.3545.5","doi-asserted-by":"crossref","unstructured":"Wong CX Ganesan AN Selvanayagam JB. Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions. Eur Heart J 2016; doi:10.1093\/eurheartj\/ehw045.","DOI":"10.1093\/eurheartj\/ehw045"},{"key":"2017011300250937000_37.48.3545.6","doi-asserted-by":"crossref","unstructured":"Kim SH Despres JP Koh KK. Obesity and cardiovascular disease: friend or foe? Eur Heart J 2016;37:3560\u20133568.","DOI":"10.1093\/eurheartj\/ehv509"},{"key":"2017011300250937000_37.48.3545.7","doi-asserted-by":"crossref","unstructured":"Celis-Morales CA Lyall DM Anderson J Iliodromiti S Fan Y Ntuk UE Mackay DF Pell JP Sattar N Gill JM. The association between physical activity and risk of mortality is modulated by grip strength and cardiorespiratory fitness: evidence from 498 135 UK-Biobank participants. Eur Heart J 2016; doi:10.1093\/eurheartj\/ehw249.","DOI":"10.1093\/eurheartj\/ehw249"},{"key":"2017011300250937000_37.48.3545.8","first-page":"1845","article-title":"Hand grip strength predicts myocardial infarction and stroke","volume":"36","author":"Taylor","year":"2015","journal-title":"Eur Heart J"},{"key":"2017011300250937000_37.48.3545.9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm243"},{"key":"2017011300250937000_37.48.3545.10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq096"},{"key":"2017011300250937000_37.48.3545.11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq009"},{"key":"2017011300250937000_37.48.3545.12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv346"},{"key":"2017011300250937000_37.48.3545.13","doi-asserted-by":"crossref","unstructured":"Gencer B Mach F. Testosterone: a hormone preventing cardiovascular disease or a therapy increasing cardiovascular events? Eur Heart J 2016;37:3569\u20133575.","DOI":"10.1093\/eurheartj\/ehv439"},{"key":"2017011300250937000_37.48.3545.14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw272"},{"key":"2017011300250937000_37.48.3545.15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.021407"},{"key":"2017011300250937000_37.48.3545.16","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw106"},{"key":"2017011300250937000_37.48.3545.17","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu107"},{"key":"2017011300250937000_37.48.3545.18","doi-asserted-by":"crossref","unstructured":"Eisen A Cannon CP Blazing MA Bohula EA Park JG Murphy SA White JA Giugliano RP Braunwald E ; IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial) Investigators. The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial. Eur Heart J 2016;37:3576\u20133584.","DOI":"10.1093\/eurheartj\/ehw377"},{"key":"2017011300250937000_37.48.3545.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1410489"},{"key":"2017011300250937000_37.48.3545.20","doi-asserted-by":"crossref","unstructured":"Jacoby DS Rader DJ. Improving cardiovascular outcomes by intensifying low density lipoprotein lowering therapy in high-risk patients. Eur Heart J 2016;37:3585\u20133587.","DOI":"10.1093\/eurheartj\/ehw447"},{"key":"2017011300250937000_37.48.3545.21","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw102"},{"key":"2017011300250937000_37.48.3545.22","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv563"},{"key":"2017011300250937000_37.48.3545.23","doi-asserted-by":"crossref","unstructured":"Moriarty PM Parhofer KG Babirak SP Cornier MA Duell PB Hohenstein B Leebmann J Ramlow W Schettler V Simha V Steinhagen-Thiessen E Thompson PD Vogt A von Stritzky B Du Y Manvelian G. Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial. Eur Heart J 2016;37:3588\u20133595.","DOI":"10.1093\/eurheartj\/ehw388"},{"key":"2017011300250937000_37.48.3545.24","doi-asserted-by":"crossref","unstructured":"Watts GF Stefanutti C. ODYSSEY ESCAPE: is PCSK9 inhibition the Trojan Horse for the use of lipoprotein apheresis in familial hypercholesterolaemia? Eur Heart J 2016;37:3596\u20133599.","DOI":"10.1093\/eurheartj\/ehw497"},{"key":"2017011300250937000_37.48.3545.25","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht528"},{"key":"2017011300250937000_37.48.3545.26","doi-asserted-by":"crossref","unstructured":"Gili S Grosso Marra W D\u2019Ascenzo F Lonni E Calcagno A Cannillo M Ballocca F Cerrato E Pianelli M Barbero U Mancone M DiNicolantonio JJ Lavie CJ Omed\u00e8 P Montefusco A Bonora S Gasparini M Biondi-Zoccai G Moretti C Gaita F. Comparative safety and efficacy of statins for primary prevention in human immunodeficiency virus-positive patients: a systematic review and meta-analysis. Eur Heart J 2016;37:3600\u20133609.","DOI":"10.1093\/eurheartj\/ehv734"},{"key":"2017011300250937000_37.48.3545.27","doi-asserted-by":"crossref","unstructured":"Idris NS Grobbee DE Burgner D Cheung MM Kurniati N Uiterwaal CS. Effects of paediatric HIV infection on childhood vasculature. Eur Heart J 2016;37:3610\u20133616.","DOI":"10.1093\/eurheartj\/ehv702"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T13:49:39Z","timestamp":1568728179000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-lookup\/doi\/10.1093\/eurheartj\/ehw662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,21]]},"references-count":27,"journal-issue":{"issue":"48","published-online":{"date-parts":[[2017,1,13]]},"published-print":{"date-parts":[[2016,12,21]]}},"alternative-id":["10.1093\/eurheartj\/ehw662"],"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehw662","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,21]]}}}